Virios Therapeutics, Inc.
Virios Therapeutics, Inc. (VIRI) Stock Overview
Explore Virios Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
206.5K
P/E Ratio
-0.00
EPS (TTM)
$-5.75
ROE
-14.13%
VIRI Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Virios Therapeutics, Inc. (VIRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $3.22.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 206.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.